• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconDiabetes

Diabetes

Page 4 of 9
HealthWhat are the risks of having a baby after 35? An expert explains the reality of advanced maternal age
By Jordyn BradleyMarch 10, 2024
HealthOne secret to preventing dementia, diabetes, and heart disease may lie in your oral health habits. Here’s the dental routine to follow
By Nicole Gull McElroyFebruary 24, 2024
Phthalates can be found in “a broad swath” of consumer products, from personal care to food packaging. The exposure of pregnant women to such chemicals may be linked to preterm birth, Dr. Leonardo Trasande, a professor of pediatrics and population health at NYL Langone Health, tells Fortune.
HealthPlastic-linked ‘hormone-disrupting chemicals’ were potentially behind 10% of U.S. preterm births in 2018, according to new research. How families can steer clear of their danger
By Erin PraterFebruary 6, 2024
HealthNFL tight end Mark Andrews assisted a critically ill passenger on board a plane. How to spot—and help during—a diabetic emergency
By Jordyn BradleyFebruary 2, 2024
HealthNorth Carolina drops coverage for Wegovy and Ozempic, with implications for anti-obesity drug market projected to hit $100B by 2030
By Simone Foxman, Madison Muller and BloombergJanuary 27, 2024
HealthThese patients had to lobby for correct diabetes diagnoses. Was their race a reason?
By Bram Sable-Smith and KFF Health NewsJanuary 9, 2024
Roughly half of the U.S. population has diabetes or its predecessor. It makes us a nation of sick people, experts say—driving up the country’s health care infrastructure and staffing needs and the cost of health care, and harming the economy in a way never seen before in U.S. history.
HealthNearly half of the U.S. population has diabetes or prediabetes—and many have no clue. Are you among them?
By Erin PraterDecember 23, 2023
FinanceRoche pushes to catch up to Novo Nordisk’s Wegovy with $3.1bn deal for obesity drugmaker Carmot
By Paula Doenecke and BloombergDecember 4, 2023
Wegovy, an injectable prescription weight-loss medicine.
HealthA ‘game-changing’ study backs Wegovy use to cut heart attacks and strokes: ‘This is not just about weight and appearance’
By Madison Muller, Naomi Kresge and BloombergNovember 11, 2023
Photo of a woman walking
LifeYour number of daily steps matter—but so does your speed. Walking at this pace may help you live longer, new research reveals
By Erin PraterOctober 27, 2023
HealthEating even 2 servings of red meat a week could significantly raise your risk of diabetes. 10 protein-packed alternatives can boost your health—and the planet’s
By Erin PraterOctober 19, 2023
HealthFast-food outlets ‘are going to be hurt’ in areas where Ozempic and Wegovy are heavily used, but the selloff in candy and beer stocks is ‘somewhat overdone’
By Lisa Pham, Dasha Afanasieva and BloombergOctober 6, 2023
HealthA daily cup of tea could help improve blood sugar. Experts say one type offers the most benefits
By Erin PraterOctober 3, 2023
HealthOzempic and Wegovy ‘significantly’ improve blood sugar and weight for the long-term, new study suggests
By Erin PraterOctober 2, 2023
a box of wegovy medication
RetailWegovy maker Novo Nordisk leapfrogs LVMH to become Europe’s most valuable company after it takes its ‘miracle’ weight loss drug to the U.K.
By Prarthana PrakashSeptember 5, 2023
1
  • 2
  • 3
  • 4
  • 5
  • 6
...9
Most Popular
Magazine
The youngest-ever female CEO of a Fortune 500 company is fighting Trump's cuts to keep Medicaid strongAn image of a popular article
By Fortune EditorsMarch 24, 2026
Commentary
The Treasury just declared the U.S. insolvent. The media missed itAn image of a popular article
By Fortune EditorsMarch 23, 2026
Success
Palantir’s billionaire CEO says only two kinds of people will succeed in the AI era: trade workers — ‘or you’re neurodivergent’An image of a popular article
By Fortune EditorsMarch 24, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.